Organic growth reached 16% with strong gains in Sleep and Respiratory Health, while divestitures and portfolio streamlining refocused the business. Profitability was impacted by West Coast contract inefficiencies and a major supplier price hike, prompting a reset in full-year guidance.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.